MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2019 International Congress

    Development of a web-based tool for systematic collection of phenotypes of hereditary movement disorders from medical literature

    J. Lee, S. Fujioka, S. Hong, N. Kim, Y. Kim, H. Ma, Y. Tsuboi, Y. Kim (Anyang, Republic of Korea)

    Objective: To develop a web-based tool to collect phenotypes of heterditary movement disorders. Background: Deep phenotyping, the precise and comprehensive analysis of phenotypic abnormalities, is…
  • 2019 International Congress

    Parkinson’s disease patients with both GBA and LRRK2 mutations are phenotypically similar to LRRK2 – a possible protective effect?

    N. Omer, A. Thaler, L. Goldstein, A. Orr-Urtreger, M. Gana Weisz, O. Goldstein, D. Cohen Avinoam, M. Kestenbaum, M. Lioti, S. John, J. Cederbaum, A. Mirelman, N. Giladi (Tel Aviv, Israel)

    Objective: To compare the phenotype of patients with Parkinson's disease (PD) who carry dual mutation in both LRRK2 and GBA genes with patients with PD…
  • 2019 International Congress

    Genetic polymorphism (rs6971) in translocator protein (TSPO) and its clinical relevance in Parkinson’s disease

    P. Surathi, M. Matarazzo, A. Sethi, J. Mckenzie, N. Neilson, R. Ross, M. Schulzer, M. Farrer, S. Booromand, J. Stoessl (Vancouver, BC, Canada)

    Objective: The objective of this study will be to identify specific clinical patterns in Parkinson’s disease patients with respect to TSPO genetic polymorphism (rs69711). Background:…
  • 2019 International Congress

    Characterization of cerebrospinal fluid profile in hereditary spastic paraparesis 10

    M. Andréasson, K. Lagerstedt-Robinson, K. Samuelsson, G. Solders, K. Blennow, M. Paucar, P. Svenningsson (Stockholm, Sweden)

    Objective: Perform a comprehensive clinical characterization and biochemical cerebrospinal fluid (CSF) profile analyses in two Swedish families with hereditary spastic paraparesis 10 (SPG10) caused by…
  • 2019 International Congress

    Prevalence of Oropharyngeal Dysphagia in Hereditary Spastic Paraplegias

    L. Jacinto-Scudeiro, G. Machado, A. Ayres, D. Burguêz, M. Polese-Bonatto, C. González-Salazar, M. Siebert, M. França Jr, M. Olchik, J. SAUTE. (Porto Alegre, Brazil)

    Objective: We aimed to assess the prevalence of swallowing disorder and to characterize the main clinical signs of dysphagia in genetically confirmed HSP patients. Background:…
  • 2019 International Congress

    PEX 16: EXPANDING THE CLINICAL SPECTRUM OF PEROXISOMAL BIOGENESIS DISORDERS

    D. N, J. Agadi (Bangalore, India)

    Objective: IDENTIFICATION OF A NOVEL PEX 16 GENE MUTATION IN A YOUNG PATIENT WITH SLOWLY PROGRESSIVE ATAXIA AND SPASTICITY. Background: PEROXISOMAL BIOGENESIS DISORDERS(PBD)  ARE CHARACTERIZED…
  • 2019 International Congress

    Acquired hepatocerebral degeneration treated with calcium disodium edetate chelation

    Z. Voysey, L. Azzopardi, B. Fiddes, S. Bradberry (Romford, United Kingdom)

    Objective: To evaluate the efficacy of calcium disodium edetate (CaNa2EDTA) chelation as a treatment for acquired hepatocerebral degeneration. Background: Acquired hepatocerebral degeneration is a rare…
  • 2019 International Congress

    Texas Biorepository of Human Induced Pluripotent Stem Cells for Studying Parkinson’s Disease

    S. Wijemanne, H. Hong, G. Choudhury, J. Kim, J. Ramirez-Castaneda, A. Papanastassiou, M. Daadi (San Antonio, TX, USA)

    Objective: To develop a biorepository of human induced pluripotent stem cells for studying Parkinson’s disease(PD). Background: Genetically engineered stem cells called “induced pluripotent stem cells”…
  • 2019 International Congress

    Augmented Brain Wave Synchronicity in Sleep in Parkinson’s Disease Patients

    A. Hohler, O. Vaou, X. Zhang, J. Wang, A. Quaicoe, F. Lombardi, R. Endelapour, J. Holsapple, P. Ivanov (Boston, MA, USA)

    Objective: Sleep dysfunction in Parkinson’s disease (PD) is a commonly reported symptom. Background: Analysis of brain wave synchronicity may help to unravel this phenomenon and…
  • 2019 International Congress

    Startle Reflex as a possible biomarker associated with REM sleep behavior disorders in the prodromal stage of Parkinson’s disease

    F. Traccis, M. Puligheddu, M. Figorilli, M. Carta, P. Devoto, G. Giua, ML. Fantini, D. Pani, M. Bortolato, R. Frau (Monserrato, Italy)

    Objective: 1. To test whether the alterations of REM sleep induced by lesions of the key areas involved in RBD pathogenesis are correlated to abnormalities…
  • « Previous Page
  • 1
  • …
  • 125
  • 126
  • 127
  • 128
  • 129
  • …
  • 217
  • Next Page »
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley